Abstract:The secreted proteins of M. tuberculosis, early secreted antigenic target 6 kDa (ESAT-6) and culture filtrate protein 10 kDa (CFP10), have been identified as antigenic proteins with potent T-cell stimulatory effects, and therefore have been the focus of tuberculosis vaccine studies. However, recent work showed that secretion of these proteins by the specialized ESAT-6 secretion system (ESX)-1 of M. tuberculosis is associated with virulence and pathogenesis. The studies demonstrated that ESAT-6 inhibits antigen-presenting cell function by reducing IL-12 production by macrophages through interrupting TLR2 signaling pathways and inducing macrophage apoptosis. However, the effect of ESAT-6 on T cells remains unexplored. To address this question, we studied the effect of recombinant ESAT-6 and CFP10 on human primary T-cell IFN-γ secretion and proliferation. ESAT-6, but not CFP10, inhibited IFN-γ production by T cells stimulated with M. tuberculosis or with anti-CD3 plus anti-CD28, in a dose-dependent manner. ESAT-6 also inhibited T-cell production of IL-17 and TNF-a, but not IL-2. Presence of CFP10 as part of the ESAT-6/CFP10 heterodimer did not affect ESAT-6 inhibition of T-cell IFN-γ production. ESAT-6 inhibited the proliferation of CD3+ cells in response to TCR stimulation. ESAT-6 decreased T-cell IFN-γ secretion by mechanisms independent of cytotoxicity or apoptosis. ESAT-6 reduced IFN-γ mRNA levels by inhibiting the expression of the transcription factors, ATF-2, c-Jun and CREB, which upregulate IFN-γ gene expression in T cells through binding to the IFN-γ proximal promoter. ESAT-6, but not CFP10, bound to T cells and inhibited expression of early activation markers without reducing phosphorylation of ZAP70, a proximal TCR signaling molecule. We conclude that ESAT-6 directly inhibits human T-cell responses by affecting TCR signaling pathways downstream of ZAP70.

ESAT-6 Inhibits IFN-γ Secretion by Mycobacterium Tuberculosis Responsive-Human T Cells (129.12)

Esat-6 Inhibits Production of Ifn-Gamma by Mycobacterium Tuberculosis-Responsive Human T Cells

Mycobacterium Tuberculosis Esx-1 System-Secreted Protein Esat-6 but Not Cfp10 Inhibits Human T-Cell Immune Responses

ESAT-6 Inhibits IL-12, but Promotes IL-23 Production of Human Dendritic Cells (56.9)

Early Secreted Antigenic Target of 6-Kda Protein Ofmycobacterium Tuberculosisprimes Dendritic Cells to Stimulate Th17 and Inhibit Th1 Immune Responses

ESAT-6 from Mycobacterium Tuberculosis Inhibits T Cell IFN-γ Production Through P38 MAP Kinase Pathway (56.28)

The Mycobacterium Tuberculosis Early Secreted Antigenic Target of 6 Kda Inhibits T Cell Interferon-γ Production Through the P38 Mitogen-activated Protein Kinase Pathway

Mycobacterium Tuberculosis Early Secreted Antigenic Target of 6 Kda (ESAT-6) Induces IL-6 Production by Macrophages Via STAT3 (MPF3P.820)

Early Secreted Antigenic Target of 6-Kda of Mycobacterium Tuberculosis Stimulates IL-6 Production by Macrophages Through Activation of STAT3

The Early Secreted Antigenic Target of 6 Kd of Mycobacterium Tuberculosis Inhibits the Proliferation and Differentiation of Human Peripheral Blood CD34+ Cells.

ESAT-6 undergoes self-association at phagosomal pH and an ESAT-6-specific nanobody restricts M. tuberculosis growth in macrophages

Immune Regulatory Activities of Early Secreted Antigenic Target of 6-Kd Protein of Mycobacterium Tuberculosis and Implications for Tuberculosis Vaccine Design

ESX-1 secreted protein ESAT-6 of Mycobacterium tuberculosis enhances the phagocytosis of RAW264.7 macrophages]

ESAT-6 undergoes self-association at phagosomal pH and an ESAT-6 specific nanobody restricts M. tuberculosis growth in macrophages

ESAT-6 DNA Vaccine for Mycobacterium Tuberculosis and Its Humoral and T-cell Response As Well As Its Protective Efficacy

The role of ESAT-6 in tuberculosis immunopathology

Cpg7909 Adjuvant Enhanced Immunogenicity Efficacy In Mice Immunized With Esat6-Ag85a Fusion Protein, But Does Not Confer Significant Protection Against Mycobacterium Tuberculosis Infection

Roles and Underlying Mechanisms of ESAT-6 in the Context of Mycobacterium Tuberculosis-Host Interaction from a Systems Biology Perspective.

Mycobacterium Tuberculosis Esat-6 Exhibits A Unique Membrane-Interacting Activity That is Not Found in Its Ortholog from Non-Pathogenic Mycobacterium Smegmatis

Mycobacterium tuberculosis ESAT6 modulates host innate immunity by downregulating miR-222-3p target PTEN

Clinical Application and Antigenicity of ESAT-6/CFP-10 Fusion Protein in Diagnosis of Tuberculosis